Market Insights Health Pharmacies OTC Products

Analgesics (Pharmacies) - Worldwide

Worldwide

Revenue in the Analgesics market is projected to reach €25.76bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.40%, resulting in a market volume of €35.12bn by 2029.
In global comparison, most revenue will be generated in China (€4,614.00m in 2024).
In relation to total population figures, per person revenues of €3.33 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Analgesics (Pharmacies) market in worldwide is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in the Analgesics (Pharmacies) market in worldwide are increasingly seeking convenience and accessibility when purchasing pain relief medications. With busy lifestyles and the need for immediate relief, customers prefer to purchase analgesics from pharmacies, where they can easily access a wide range of products and receive expert advice from pharmacists. Additionally, customers are becoming more conscious about the ingredients and potential side effects of analgesics, leading to a growing demand for natural and organic pain relief options.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in worldwide is the growing popularity of online pharmacies. With the increasing penetration of smartphones and internet access, customers are opting for the convenience of online shopping for their pain relief needs. Online pharmacies offer a wide range of analgesics, competitive prices, and doorstep delivery, making it an attractive option for customers. Moreover, online pharmacies often provide detailed product information and customer reviews, enabling customers to make informed decisions. Another trend in the market is the rising demand for specialized analgesics. Customers are seeking targeted pain relief solutions for specific conditions such as migraines, arthritis, and menstrual cramps. This has led to the development of analgesics that are specifically formulated to address these conditions, providing more effective and tailored pain relief options. Additionally, there is a growing demand for combination analgesics that contain multiple active ingredients to target different types of pain.

Local special circumstances: In certain countries, there are specific regulations and restrictions on the sale of analgesics in pharmacies. For example, some countries require a prescription for certain types of analgesics, limiting their availability in pharmacies. In such cases, customers may need to visit a healthcare professional before being able to purchase these medications. Additionally, some countries have price controls or reimbursement policies that impact the pricing and availability of analgesics in pharmacies.

Underlying macroeconomic factors: The growth of the Analgesics (Pharmacies) market in worldwide is also influenced by underlying macroeconomic factors. Factors such as population growth, increasing disposable income, and improving healthcare infrastructure contribute to the expansion of the market. As the population continues to grow and age, the demand for pain relief medications is expected to increase. Moreover, rising disposable incomes enable customers to afford higher-priced analgesics and explore premium pain relief options. Additionally, improvements in healthcare infrastructure, including the expansion of pharmacies and the availability of trained pharmacists, contribute to the accessibility and growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.